ZB
TARO

Zions Bancorporation’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Zions Bancorporation’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-53
Closed -$6K – 1002
2017
Q3 		$6K Buy
53
+37
+231% +$4.03K ﹤0.01% 924
2017
Q2 		$2K Sell
16
-9
-36% -$1.02K ﹤0.01% 615
2017
Q1 		$3K Sell
25
-59
-70% -$6.53K ﹤0.01% 605
2016
Q4 		$9K Buy
+84
New +$8.8K ﹤0.01% 539

Other funds holding TARO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
FL
Fort LP Chevy Chase, Maryland $39.6M AUM 37.11% 1-Year Est. Return

Zions Bancorporation's TARO Position: Q4 2017 in Review

Zions Bancorporation sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q4 2017, closing a stake of 53 shares — an estimated $6K sold.

Zions Bancorporation first reported a position in TARO in Q4 2016 and held it in 4 quarters. The position peaked at $9K in Q4 2016. 127 funds tracked by Wall St. Rank hold TARO as of Q4 2017.

  • Zions Bancorporation reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q4 2017 after selling out during the quarter.
  • Zions Bancorporation sold 53 Taro Pharmaceutical Industries Ltd. shares in Q4 2017, an estimated $6K.
  • Zions Bancorporation first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2016 and held it in 4 quarters.
  • Zions Bancorporation's Taro Pharmaceutical Industries Ltd. position peaked at $9K in Q4 2016.
  • 127 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2017.

Based on Zions Bancorporation's 13F filing for Q4 2017, filed 14 Feb 2018.